G&E Herbal Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	309.13	249.03	181.44	64.61	24.57
Revenue Growth (YoY)	24.13%	37.25%	180.84%	162.94%	-12.96%
Cost of Revenue	45.91	43.69	36.86	25.25	14.95
Gross Profit	263.22	205.34	144.59	39.35	9.63
Selling, General & Admin	76.03	50.36	39.3	19.48	16.65
Research & Development	34.89	35.34	24.6	14.39	12.54
Operating Expenses	110.92	85.7	63.9	33.87	29.19
Operating Income	152.3	119.65	80.68	5.49	-19.56
Interest Expense	-0.03	-0.04	-0	-	-
Interest & Investment Income	6.55	4.48	4.4	0.6	0.52
Currency Exchange Gain (Loss)	-	0.03	0.01	1.06	-0.39
Other Non Operating Income (Expenses)	-0.43	0.63	0.31	0.08	0
EBT Excluding Unusual Items	158.39	124.74	85.4	7.23	-19.43
Gain (Loss) on Sale of Assets	-	-0.01	-0.01	-0	-0.02
Legal Settlements	-	-	5.12	-	-
Other Unusual Items	-	-	-	-	1.22
Pretax Income	158.39	124.73	90.5	7.23	-18.22
Income Tax Expense	19.2	22.67	18.1	-0.15	1.66
Net Income	139.2	102.06	72.4	7.38	-19.88
Net Income to Common	139.2	102.06	72.4	7.38	-19.88
Net Income Growth	36.38%	40.97%	880.90%	-	-
Shares Outstanding (Basic)	64	64	64	64	64
Shares Outstanding (Diluted)	64	64	64	64	64
Shares Change (YoY)	0.07%	0.06%	0.08%	-	-
EPS (Basic)	2.18	1.60	1.14	0.12	-0.31
EPS (Diluted)	2.18	1.60	1.14	0.11	-0.31
EPS Growth	36.10%	40.97%	900.19%	-	-
Free Cash Flow	66.98	128.76	107.96	97.01	-10.96
Free Cash Flow Per Share	1.05	2.02	1.69	1.52	-0.17
Dividend Per Share	-	0.701	0.498	-	-
Dividend Growth	-	40.75%	-	-	-
Gross Margin	85.15%	82.46%	79.69%	60.91%	39.17%
Operating Margin	49.27%	48.04%	44.47%	8.49%	-79.61%
Profit Margin	45.03%	40.98%	39.90%	11.42%	-80.92%
Free Cash Flow Margin	21.67%	51.70%	59.50%	150.15%	-44.61%
EBITDA	162.91	129.24	89.9	14.89	-10.23
EBITDA Margin	52.70%	51.90%	49.55%	23.04%	-41.62%
D&A For EBITDA	10.61	9.59	9.22	9.4	9.33
EBIT	152.3	119.65	80.68	5.49	-19.56
EBIT Margin	49.27%	48.04%	44.47%	8.49%	-79.61%
Effective Tax Rate	12.12%	18.17%	20.00%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.